MinYGMoonYKwonYN, et al. Prognostic factors of first-onset optic neuritis based on diagnostic criteria and antibody status: A multicentre analysis of 427 eyes. J Neurol Neurosurg Psychiatry2024; 95(8): 753–760.
2.
ShahmohammadiSDoostiRShahmohammadiA, et al. Autoimmune diseases associated with neuromyelitis optica spectrum disorders: A literature review. Mult Scler Relat Disord2019; 27: 350–363.
3.
KwonSHanKDJungJH, et al. Risk of autoimmune rheumatic diseases in multiple sclerosis and neuromyelitis optica spectrum disorder: A nationwide cohort study in South Korea. Mayo Clin Proc2025; 100(5): 801–813.
4.
SamiFSamiSAManadanAM, et al. Nationwide analysis of neuromyelitis optica in systemic lupus erythematosus and Sjogren’s syndrome. Clin Rheumatol2024; 43(1): 59–65.
5.
AkaishiTTakahashiTFujiharaK, et al. Risk factors of attacks in neuromyelitis optica spectrum disorders. J Neuroimmunol2020; 343: 577236.
6.
KrettJDFilippatouAGBarrerasP, et al. “Lupus myelitis” revisited: A retrospective single-center study of myelitis associated with rheumatologic disease. Neurol Neuroimmunol Neuroinflamm2025; 12(1): e200329.
7.
JariusSJacobiCde SezeJ, et al. Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders. Mult Scler2011; 17(9): 1067–1073.
8.
EstiasariRMatsushitaTMasakiK, et al. Comparison of clinical, immunological and neuroimaging features between anti-aquaporin-4 antibody-positive and antibody-negative Sjogren’s syndrome patients with central nervous system manifestations. Mult Scler2012; 18(6): 807–816.
9.
AkaishiTTakahashiTFujiharaK, et al. Impact of comorbid Sjögren syndrome in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders. J Neurol2021; 268(5): 1938–1944.
10.
WuWYangWDengB, et al. Concomitant Sjögren’s disease in patients with NMOSD: impacts on neurologic disease severity and recurrence. Arthritis Res Ther2025; 27(1): 78.
